Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis.
Patients with liver cirrhosis and hepatocellular carcinoma (HCC) are often ineligible for resection or local ablation therapy due to poor liver function and/or difficult location. The aim of this study is to evaluate therapeutic outcomes of stereotactic body radiotherapy (SBRT) combined with transar...
Main Authors: | Baek Gyu Jun, Sang Gyune Kim, Young Don Kim, Gab Jin Cheon, Koon Hee Han, Jeong-Ju Yoo, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Suyeon Park, Hong Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6209230?pdf=render |
Similar Items
-
Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
by: Min Young Baek, et al.
Published: (2019-11-01) -
Hepatobronchial Fistula and Lung Abscess after Transarterial Chemoembolization
by: Kwanjoo Lee, et al.
Published: (2017-05-01) -
Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
by: Kil Hyo Park, et al.
Published: (2015-06-01) -
Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis
by: Yoon Seung, et al.
Published: (2008-11-01) -
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
by: Hao Hu, et al.
Published: (2014-01-01)